Insiders and hedge funds are unloading millions of this company's shares, but instead of selling, I'm doing this...
I've been buying shares of a large cap, deeply discounted global pharmaceutical giant who is currently working with the U.S. Army to develop a Zika vaccine that should be ready for human trials by October of this year. You should, too.
Afraid of another pullback in the markets? Here's what you need to watch for...
It's a fact of life that corporate executives -- and successful game-changing stock investors -- know too well: it's easier to buy something than to build it from scratch.
These are solid companies that you can feel confident buying and holding onto for years, even decades. Click here for the names of these stocks.
Looking at the pharmaceutical industry, one company stood out for its pipeline of upcoming drugs and the potential for higher profits over the next few years.
A $4.1 billion investment in a property in struggling Macau could mean losses in the short term for this popular vacation stock. But what might the future hold?
A recent breakout sets shares up for a rally to last year's highs and possibly beyond.
By following the owners of the 50 largest hedge funds, investors may be able to profit as one company heads higher, while at the same time reducing market risk by shorting another other. Details here.
Harley-Davidson just received some troubling news from the EPA... but is everything as bad as it seems? Click here for details.